Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation

Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts

(2016) Rosy Dabas et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Rabbit Anti–T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation

(2015) Jan Storek et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality

(2015) A. Mancusi et al.   BLOOD

Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis

(2015) A B M Lim et al.   BONE MARROW TRANSPLANTATION

The Role of the Killer Cell Immunoglobulin-Like Receptor (KIR) “Missing Self” Model in Unrelated Donor HSCT: A Meta-analysis

(2015) S. Wu et al.   TRANSPLANTATION PROCEEDINGS

Immune Cell Subset Counts Associated with Graft-versus-Host Disease

(2014) Peter J. Podgorny et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation

(2014) N. N. Shah et al.   BLOOD

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

(2014) A. K. Moesta et al.   JOURNAL OF IMMUNOLOGY

Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

(2014) S. Cooley et al.   JOURNAL OF IMMUNOLOGY

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations

(2014) Faviel F. González-Galarza et al.   NUCLEIC ACIDS RESEARCH

Fludarabine, Busulfan, Antithymocyte Globulin, and Total Body Irradiation for Pretransplantation Conditioning in Acute Lymphoblastic Leukemia: Excellent Outcomes in All but Older Patients with Comorbidities

(2012) Andrew Daly et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD

(2012) L M Pratt et al.   BONE MARROW TRANSPLANTATION

Immune reconstitution after hematopoietic cell transplantation

(2012) Mark Bosch et al.   CURRENT OPINION IN HEMATOLOGY

Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation

(2012) Mark Bosch et al.   CYTOTHERAPY

HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1

(2012) Jeffrey M. Venstrom et al.   NEW ENGLAND JOURNAL OF MEDICINE

NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions

(2011) B. Foley et al.   BLOOD

Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors

(2011) Mette Hoegh-Petersen et al.   CYTOTHERAPY

Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies

(2010) Kate Stringaris et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients

(2010) Alejandra Ugarte-Torres et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

(2010) S. Cooley et al.   BLOOD

NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

(2010) J. A. Olson et al.   BLOOD

Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT

(2010) S Giebel et al.   BONE MARROW TRANSPLANTATION

Rabbit Anti T-Lymphocyte Globulin Induces Apoptosis in Peripheral Blood Mononuclear Cell Compartments and Leukemia Cells, While Hematopoetic Stem Cells Are Apoptosis Resistant

(2009) Carsten Grüllich et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The Role of Missing Killer Cell Immunoglobulin-Like Receptor Ligands in T Cell Replete Peripheral Blood Stem Cell Transplantation from HLA-Identical Siblings

(2009) Johannes Clausen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

The influence of NK alloreactivity on matched unrelated donor and HLA identical sibling haematopoietic stem cell transplantation

(2009) Campbell S Witt   CURRENT OPINION IN IMMUNOLOGY

Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation

(2009) Sebastian Giebel et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Effects of the NK Cell Recovery on Outcomes of Unmanipulated Haploidentical Blood and Marrow Transplantation for Patients with Hematologic Malignancies

(2008) Ying-Jun Chang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation

(2008) L. Vago et al.   BLOOD

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

(2008) S. Cooley et al.   BLOOD

Donor Killer Immunoglobulin-Like Receptor (KIR) Genotype-Patient Cognate KIR Ligand Combination and Antithymocyte Globulin Preadministration Are Critical Factors in Outcome of HLA-C-KIR Ligand-Mismatched T Cell–Replete Unrelated Bone Marrow Transplantation

(2007) Toshio Yabe et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation

(2007) Jennifer Schellekens et al.   MOLECULAR IMMUNOLOGY